论文部分内容阅读
目的:观察丹奥治疗急性脑梗死的临床疗效。方法:选择60例急性脑梗死患者随机分为治疗组和对照组。治疗组在常规药物治疗的基础上静脉使用丹奥80 mg,1次/d,14 d为1疗程。对照组给予丹参20 ml静脉滴注,1次/d共14 d,治疗后两组病例进行疗效比较。结果:治疗组显效率为80%,总有效率为90%;对照组显效率为40%,总有效率为66.6%。两组患者的显效率及总有效率比较,差异具有显著性意义(P<0.01)。结论:丹奥治疗急性脑梗死疗效确切,安全性好,值得推广使用。
Objective: To observe the clinical efficacy of Danio in the treatment of acute cerebral infarction. Methods: Sixty patients with acute cerebral infarction were randomly divided into treatment group and control group. The treatment group on the basis of conventional drug therapy, intravenous Danao 80 mg, 1 / d, 14 d for a course of treatment. The control group was given intravenous drip of Salvia 20 ml once a day for 14 days. After treatment, the curative effect of the two groups was compared. Results: The effective rate of the treatment group was 80%, the total effective rate was 90%; the effective rate of the control group was 40%, the total effective rate was 66.6%. The two groups of patients markedly effective rate and total effective rate, the difference was significant (P <0.01). Conclusion: Danio treatment of acute cerebral infarction is effective, safe and worthy of promotion.